News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected
Viromed Medical AG partners with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care®, expecting additional earnings contribution of EUR 0.28 to EUR 0.34 per share from 2025 onwards -
COMMUNIQUÉ DE PRESSE
Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds
